p53 Autoantibodies in Patients with Autoimmune Diseases: A Quantitative Approach

References

• Fishmiin, P. Mcrimsky. O. and 'Shocnfeld. Y. Autoimmu-nit> and cancer beneficial relationships: A new concept for the production of human monoclonal antibodies. Int. J. Oncol. 1997; 10: 901–904.
   Google Scholar
• Mowat. M.R.A. p53 in tumor progression: Life, death. and everything. Adv. Cancer Res. 1998: 74: 25–48.
   PubMed Web of Science ®Google Scholar
• Alvarado-de la Barrera. C. Alcocer-Varela. J. Richaud-Patin. Y., Alarcon-Scgovia. D. and Llorente, L. Differential oncogene and TNF-o mRNA expression in bone marrow cells from systemic lupus erythematosus patients. Scuml. J. Immunol. 1998: 48: 551 556.
   Google Scholar
• Hollstcin, M. Sidransky. D. Vogelstcin. B. and Harris. C. p53 mutations in human cancers. Science 1991: 253: 49 53.
   Google Scholar
• Schlichthob. B. Legros. Y., Gillet. D. Gaillard. C. Marty. M. Lane. D. Calvo. F. and Soussi. T. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spots. Cancer Res. 1992; 52: 6380–6384.
   Google Scholar
• Labrecque. S. Naor. N. Thomson. D. and Matlashcwski. G. Analysis of the anti-p53 antibody response in cancer patients. Cancer Res. 1993: 53: 3468–3471.
   Google Scholar
• Peyrat. J.-P., Bonnetcrrc. J., Lubin. R. Vanlemmcns. L. Fournicr. J. and Soussi. T. Prognostic significance of circulating p53 antibodies in patients undergoing surgery for locoregional breast cancer. Lancet 1995: 345: 621 622.
   Google Scholar
• Wiirl. P. Weigmann. F. Mcyc. A. Fittkau. M. Rose, U. Berger. D. Rath. F.W., Dralle. H. and Taubert. H. Detection of p53 autoantibodies in sera of gastric cancer patients and their prognostic relevance. Semiti. J. Gastroenterol. 1997:32: 1147–1151.
   Google Scholar
• Houbiers. J.G.A. van der Burg. S.H. van de Watering. L.M.G. Tollenaar. R.A.E.M. Brandt. A., van de Vclde. C.J.H. and Melief. C.J.M. Antibodies against p53 are associated with poor prognosis of colorectal cancer. Br. J. Cancer 1995: 72: 637–641.
   PubMed Web of Science ®Google Scholar
• Ruiz. P.J. Wolkowicz. R. Waisman. A. Hirschbcrg. D.L. Carmi. P. Ercz. N. Garren. H. Hcrkel. J. Karpuj. M. Steinman. L., Rotter. V. and Cohen. I.R. Idiotypic immunization induces immunity to mutated p53 and tumor rejection. Nature Medicine 1998: 6: 710 712.
   Google Scholar
• Yashar, CM. Gercel-Taylor. C. Gibb. R.K. Weeks. J.W. and Taylor. D.D. Identification of a unique form of p53 in human cord blood associated with the development of maternal autoantibodies. Am. J. Reprod. Immunol. 1998: 39: 368–375.
   Google Scholar
• Chen. Y.M.A. Chen. S.H. Fu. C.Y. Chen. J.Y. and Osarne. M. Antibody reactivities to tumor-suppressor protein p53 and HTLV-1 Tof. Rex and Tax in HTLV-I-infected people with differing clinical status. Int. J. Cancer 1997:71: 196–202.
   Google Scholar
• Marxsen. J. Schmiegcl. W. Rider. C. Harder, R. Juhl. H. Hannc-Bruhns. D. Krcmcr. B. and KaltholT. H. Detection of the anti-p53 antibody response in malignant and benign pancreatic disease. Br. J. Cancer 1994; 70: 1031–1034.
   Google Scholar
• Kovacs. B. Patel. A. Hershey. J.N. Dennis. G.J. Kirschfink, M. and Tsokos, G.C. Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum. 1997: 40: 980–982.
   Google Scholar
• Tan. E.M. Cohen. A.S. Fries. J.F. Masi. A.T. McShane. D.J. Rothficld. N.F. Schaller. J.G. Talai. N. and Winchester. R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982:25: 1271 1277.
   Google Scholar
• Nedbal, W. Frcy, M. Willcmann, B. Zcntgraf. H. and Sczakicl. G. Mechanistic insights into p53-promoted RNA-RNA annealing. J. Mol. Biol. 1997: 266: 677 687.
   Google Scholar
• Angclopoulou, K. Diamandis, E.P. Sutherland. D.J.A. Kellcn. J.A. and Bunting, P.S. Prevalence of scrum antibodies against the p53 tumour gene protein in various cancers. iiiL.1. Cancer 1994; 58: 480–487.
   Google Scholar
• Winter. S.F. Minna. J.D. Johnson. B.E., Takahashi. T. Gazdar. A.F. and Carbone. D.P. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type ofp53 mutation. Cancer Res. 1992: 52: 4168–4174.
   Google Scholar
• Davidoff. A.M. Iglchart. J.D. and Marks. J.R. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. Natl. Acad. Sci. 1992; 89: 3439–3442.
   PubMed Web of Science ®Google Scholar
• Prcudhommc, C. Lubin, R. Lcpellcy. P., Vanrumbcke. M. and Fenaux. P. Detection of scrum anti-p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia. Leukemia 1994; 8: 1589 1591.
   Google Scholar
• Wild. C.P. Ridanpiiii, M. Anttila. S., Lubin. R. Soussi. T., Husgafvel-Fursiainen. K. and Vanino. H. p53 antibodies in the sera of lung cancer patients: comparison with p53 mutation in the tumour tissue. Int. J. Cancer 1995:64: 176–181.
   Google Scholar
• Cawlcy. H.L. Meltzer. S.J., De Benedetti. V.M.G. Hollstein, M.C., Muchlbauer, K.R., Liang, L., Bcnett. W.P. Souza. R.F. Greenwald. B.D., Cottrell, J. Salabes. A., Bartsch, H. and Trivers, G.E. Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. Gastroenterology 1998: 115: 19–27.
   Google Scholar
• Dong. X. Hamilton. K.J. Satoh. M. Wang. J. and Reeves. W.H. Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen. J. Exp. Med. 1994; 179: 1243 1252.
   Google Scholar
• Lubin. R. Schlichtholz. B. Teillaud. J.L. Garay. E. Bussel, A. Wild, C.P. and Soussi. T. Serum p53 antibodies as early markers of lung cancer. Nature Med. 1995; 1: 701–702.
   Google Scholar
• Trivers. G. Cawlcy. H.L., De Benedetti. V.M.G. Hollstein, M., Marion, M.J., Bcnett. W.P. Hoover, M.L. Prives, C.C., Tamburro. C.C. and Harris, C.C. Anti-p53 antibodies in sera of workers occupationally exposed to vinyl chloride. J. Natl. Cancellasi. 1995: 87: 1400–1407.
   Google Scholar
• Trivers. G.E. De Benedetti. V.M.G. Cawley. H.L. Caron, G., Harrington, A.M., Bennett. W.P., Jctt. J.R., Colby. T.V., Tazclaar. H., Pairolero. P. Miller, D. and Harris. C.C. Anti-p53 antibodies in sera from patients with chronic obstructive pulmonary disease can predate a diagnosis of cancer. Clin. Cancer Res. 1996: 2: 1767–1775.
   Google Scholar